Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 31, 2014, Pages 10900-10907

  Teng, Fei ^a   Wang, Gui Hua ^a   Tao, Yi Feng ^a   Guo, Wen Yuan ^a   Wang, Zheng Xin ^a   Ding, Guo Shan ^a   Shi, Xiao Min ^a   Fu, Zhi Ren ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Criteria; Hepatocellular carcinoma; Liver transplantation; MHCAT; Survival model

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; AFP PROTEIN, HUMAN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; CANCER PATIENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MODEL; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; RETRANSPLANTATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT SYSTEM; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; OPERATIVE BLOOD LOSS; PATHOLOGY; PREDICTIVE VALUE; REGISTER; REOPERATION; TIME; TREATMENT OUTCOME;

ADULT; ALPHA-FETOPROTEINS; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84909580345     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i31.10900     Document Type: Article

References (21)

1. Adam R, Karam V, Delvart V, O'Grady J, Mirza D, Klempnauer J, Castaing D, Neuhaus P, Jamieson N, Salizzoni M, Pollard S, Lerut J, Paul A, Garcia-Valdecasas JC, Rodríguez FS, Burroughs A. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675-688 [PMID: 22609307 DOI: 10.1016/j.jhep.2012.04.015]
2. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, Harper AM, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant 2013; 13 Suppl 1: 73-102 [PMID: 23237697]
3. China Liver Transplant Registry. CLTR 2011 Annual Scientific Report. 2013-05-03, cited 2013-12-27. Available from: URL: http://www.cltr.org/pages/datainfo/datainfo-apparatus.jsp?subType=11
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104]
5. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012; 13: e11-e22 [PMID: 22047762 DOI: 10.1016/S1470-2045(11)70175-9]
6. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007; 7: 2587-2596 [PMID: 17868066 DOI: 10.1111/j.1600-6143.2007.01965.x]
7. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563]
8. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008; 85: 1726-1732 [PMID: 18580463 DOI: 10.1097/TP.0b013e31816b67e4]
9. Fan J, Yang GS, Fu ZR, Peng ZH, Xia Q, Peng CH, Qian JM, Zhou J, Xu Y, Qiu SJ, Zhong L, Zhou GW, Zhang JJ. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol 2009; 135: 1403-1412 [PMID: 19381688 DOI: 10.1007/s00432-009-0584-6]
10. Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, Neuhaus P, Klempnauer J, Pratschke J, Manns MP, Strassburg CP. Multicentric evaluation of model for endstage liver disease-based allocation and survival after liver transplantation in Germany - limitations of the 'sickest first'-concept. Transpl Int 2011; 24: 91-99 [PMID: 20819196 DOI: 10.1111/j.1432-2277.2010.01161.x]
11. Silva MF, Sherman M. Criteria for liver transplantation for HCC: what should the limits be? J Hepatol 2011; 55: 1137-1147 [PMID: 21718672 DOI: 10.1016/j.jhep.2011.05.012]
12. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10: 911-918 [PMID: 15237377 DOI: 10.1002/lt.20140]
13. Vibert E, Azoulay D, Hoti E, Iacopinelli S, Samuel D, Salloum C, Lemoine A, Bismuth H, Castaing D, Adam R. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 2010; 10: 129-137 [PMID: 20070666 DOI: 10.1111/j.1600-6143.2009.02750.x]
14. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, Trevisani F, Grigioni WF, Bolondi L, Pinna AD. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78: 1780-1786 [PMID: 15614151]
15. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16: 262-278 [PMID: 20209641 DOI: 10.1002/lt.21999]
16. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS, Emond JC. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537-2546 [PMID: 18945283 DOI: 10.1111/j.1600-6143.2008.02400.x]
17. Weismüller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008; 43: 736-746 [PMID: 18569992 DOI: 10.1080/00365520801932944]
18. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9: 970-981 [PMID: 19341419 DOI: 10.1111/j.1600-6143.2009.02571.x]
19. Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M, Ikeda K, Kumada H, Watanabe G. Factors associated with early cancer-related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion. J Hepatobiliary Pancreat Sci 2014; 21: 142-147 [PMID: 23798352 DOI: 10.1002/jhbp.13]
20. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-623 [PMID: 19300227 DOI: 10.1097/SLA.0b013e31819ed22f]
21. Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y, Kayashima H, Sugimachi K, Aishima S, Yamashita Y, Ikegami T, Gion T, Uchiyama H, Soejima Y, Maeda T, Shirabe K, Maehara Y. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2010; 17: 2740-2746 [PMID: 20411432 DOI: 10.1245/s10434-010-1076-2]